Jl. Bussiere et al., PLASMA-LIPOPROTEIN (A) CONCENTRATION AND POSTANGIOPLASTY RESTENOSIS, Archives des maladies du coeur et des vaisseaux, 89(4), 1996, pp. 425-429
Lipoprotein (a) [Lp(a)] is an independent genetically determined marke
r of coronary artery disease. It is present in the atheromatous plaque
with a molecular structure similar to that of plasminogen. Its role i
n postangioplasty restenosis is a possibility but is controversial. A
population of 103 coronary patients underwent angioplasty with control
coronary angiography before the 6th month; there were 53 good results
and SO cases of restenosis. The Lp(a) was measured by immunonepheleme
try (threshold value of 250 mg/l). A subgroup with Lp(a) concentration
s > 250 mg/l was identified. The average concentrations of Lp(a) in th
e two groups without restenosis (368 +/- 350 mg/l) and with restenosis
(418 +/- 434 mg/l) were not statisticaly different (p = 0.2). When ca
ses with Lp(a) > 250 mg/l were considered alone, the tendency to highe
r average concentrations of Lp(a) in the group with restenosis (777 +/
- 424 mg/l) compared with the group without restenosis (656 +/- 340 mg
/l) was more clear-cut but did not achieve statistical significance (p
= 0.08). The individual scatter of Lp(a) being very wide (83 to 1450
mg/l in the group without restenosis and 90 to 1740 mg/l in the group
with restenosis), it is impossible to predict restenosis from this par
ameter in a given individual. No correlations were observed between th
e different lipid fractions and restenosis. The extension of the lesio
ns and the angioplasty site did not correlate with restenosis in this
study. The authors conclude : 1) that the Lp(a) concentration has no i
ndividual predictive value for restenosis ; 2) individuals with Lp(a)
concentrations > 250 mg/l have an increased risk of restenosis (NS); 3
) these results confirm other recent publications; and 4) further rese
arch into the isoforms of Lp(a) in each group could provide interestin
g data.